You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

15 Results
Guidelines and Advice
Status: Archived
ID: CED 20
Mar 2011
Guidelines and Advice
Status: Archived
ID: 1-20
Version: 2
Oct 2011
Guidelines and Advice
Status: Archived
ID: CED 23
Oct 2011
Guidelines and Advice
Status: Archived
ID: 1-12
Sep 2011
Guidelines and Advice
Status: Archived
ID: 2-18
Jun 2011
Guidelines and Advice
Status: Archived
ID: 2-22
Sep 2011
Guidelines and Advice
Status: Archived
ID: 21-3-3
Jan 2011
Guidelines and Advice
Status: Archived
ID: 8-4
Sep 2011
Guidelines and Advice
Status: Archived
ID: 1-15 Version 3
Version: 3
Sep 2011
Guidelines and Advice
Status: Current
ID: GL 6-A-2023-1
Version: 2
Updated
Jan 2026
Regimen
Cancer Type:
Head and Neck, 
Nasopharynx
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
toripalimab (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Feb 2026
Regimen
Cancer Type:
Skin, 
Melanoma
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Tebentafusp (Outpatient) - Unresectable or Metastatic Uveal Melanoma
High Cost Therapy Funding Program
    Tebentafusp (Inpatient) - Unresectable or Metastatic Uveal Melanoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
tebentafusp
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Mar 2026

Pages